Indoco Remedies added 2.68% to Rs 317.55 after the company has received tentative approval from the US Food and Drug administration (USFDA) for its abbreviated new drug application (ANDA) for canagliflozin and metformin tablets.
Subscribe To Our Free Newsletter |